A detailed history of Nissay Asset Management Corp transactions in Royalty Pharma PLC stock. As of the latest transaction made, Nissay Asset Management Corp holds 44,363 shares of RPRX stock, worth $1.14 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
44,363
Previous 43,759 1.38%
Holding current value
$1.14 Million
Previous $1.23 Million 9.6%
% of portfolio
0.01%
Previous 0.01%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$27.46 - $31.33 $16,585 - $18,923
604 Added 1.38%
44,363 $1.35 Million
Q4 2023

Feb 14, 2024

BUY
$26.21 - $29.22 $70,583 - $78,689
2,693 Added 6.56%
43,759 $1.23 Million
Q3 2023

Nov 14, 2023

BUY
$26.26 - $31.38 $49,132 - $58,711
1,871 Added 4.77%
41,066 $1.11 Million
Q2 2023

Aug 14, 2023

BUY
$29.6 - $36.56 $66,156 - $81,711
2,235 Added 6.05%
39,195 $1.2 Million
Q1 2023

May 15, 2023

SELL
$32.77 - $39.4 $41,093 - $49,407
-1,254 Reduced 3.28%
36,960 $1.33 Million
Q4 2022

Feb 14, 2023

SELL
$39.17 - $44.04 $12,573 - $14,136
-321 Reduced 0.83%
38,214 $1.51 Million
Q3 2022

Nov 14, 2022

BUY
$39.88 - $44.65 $68,115 - $76,262
1,708 Added 4.64%
38,535 $1.55 Million
Q2 2022

Aug 15, 2022

BUY
$37.53 - $44.22 $3,340 - $3,935
89 Added 0.24%
36,827 $1.55 Million
Q1 2022

May 16, 2022

BUY
$37.46 - $42.44 $38,321 - $43,416
1,023 Added 2.86%
36,738 $1.43 Million
Q4 2021

Feb 14, 2022

BUY
$35.17 - $42.48 $589,484 - $712,007
16,761 Added 88.43%
35,715 $1.42 Million
Q3 2021

Nov 10, 2021

BUY
$36.14 - $42.24 $29,779 - $34,805
824 Added 4.54%
18,954 $685,000
Q2 2021

Aug 13, 2021

BUY
$39.85 - $46.63 $8,009 - $9,372
201 Added 1.12%
18,130 $743,000
Q1 2021

May 11, 2021

BUY
$42.34 - $52.82 $214,071 - $267,057
5,056 Added 39.28%
17,929 $782,000
Q4 2020

Feb 08, 2021

BUY
$36.12 - $50.05 $464,972 - $644,293
12,873 New
12,873 $644,000

Others Institutions Holding RPRX

About Royalty Pharma plc


  • Ticker RPRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 437,139,008
  • Market Cap $11.2B
  • Description
  • Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...
More about RPRX
Track This Portfolio

Track Nissay Asset Management Corp Portfolio

Follow Nissay Asset Management Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nissay Asset Management Corp , based on Form 13F filings with the SEC.

News

Stay updated on Nissay Asset Management Corp with notifications on news.